This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bikenbiomics Co., Ltd., Osaka University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2020
Title: Takuya Yoshida: Innovator in Peptide Research
Introduction
Takuya Yoshida is a notable inventor based in Suita, Japan. He has made significant contributions to the field of peptide research, particularly in the development of inhibitors for pathogenic bacteria. His innovative work has implications for improving digestive health and combating bacterial infections.
Latest Patents
Takuya Yoshida holds a patent titled "Peptide inhibiting colonization by pathogenic bacteria, and colonization inhibitor including same." This patent describes a peptide capable of preventing pathogenic bacteria from colonizing in digestive organs. The peptide comprises a first domain with an amino acid sequence that binds to a minor pilin of IVb fimbriae, and a second domain that allows for multimerization. The second domain is connected to the first domain via a linker sequence. This invention has the potential to enhance health outcomes by targeting harmful bacteria in the digestive system.
Career Highlights
Throughout his career, Takuya Yoshida has worked with esteemed institutions such as Osaka University and Bikenbiomics Co., Ltd. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Takuya Yoshida's notable coworkers include Shota Nakamura and Daisuke Motooka. Their collaborative efforts have further advanced the research and development of innovative solutions in the realm of peptide technology.
Conclusion
Takuya Yoshida's work in peptide research exemplifies the impact of innovation in addressing health challenges. His patent and collaborations highlight the importance of scientific advancement in improving human health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile